Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis

AIMS: Neurocysticercosis is the most common cause of acquired epilepsy in the world. Antiparasitic treatment of viable brain cysts is of clinical benefit, but current antiparasitic regimes provide incomplete parasiticidal efficacy. Combined use of two antiparasitic drugs may improve clearance of bra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Garcia, Hector H, Lescano, Andres G, Lanchote, Vera L, Pretell, E Javier, Gonzales, Isidro, Bustos, Javier A, Takayanagui, Osvaldo M, Bonato, Pierina S, Horton, John, Saavedra, Herbert, Gonzalez, Armando E, Gilman, Robert H
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Science Inc 2011
Materias:
Pharmacokinetics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3141188/
https://ncbi.nlm.nih.gov/pubmed/21332573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2011.03945.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares